Bradykinin
- Generic Name
- Bradykinin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C50H73N15O11
- CAS Number
- 58-82-2
- Unique Ingredient Identifier
- S8TIM42R2W
- Background
Bradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
- Associated Conditions
- -
- Associated Therapies
- -
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT03738878
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Comparative Effects of Aspirin and NHP-544C
- Conditions
- Healthy
- Interventions
- Drug: BradykininDrug: Aspirin 81 mgDrug: NHP544-C 81 mgDrug: Aspirin 162 mgDrug: NHP544C 162 mgDrug: Placebo
- First Posted Date
- 2014-07-14
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 61
- Registration Number
- NCT02189122
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
- Conditions
- Diabetes Type 2Hypertension
- Interventions
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 44
- Registration Number
- NCT01413542
- Locations
- 🇺🇸
Vanderbilt University- General Clinic Research Center, Nashville, Tennessee, United States
Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 16
- Registration Number
- NCT00868855
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Brachial Artery t-PA Release in Heart Transplant Recipients
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2016-07-15
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00780637
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00780377
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2017-07-14
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 13
- Registration Number
- NCT00780481
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Endothelial Hyperpolarization in Humans
- Conditions
- Hyperlipidemia
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Emory University
- Target Recruit Count
- 174
- Registration Number
- NCT00166166
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.